Prevalence of factor V Leiden, prothrombin and methylene tetrahydrofolate reductase mutations in women with adverse pregnancy outcomes in Lebanon

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 4, 2006, Pages 1114-1118

  Zahed, Laila F ^a   Rayes, Roni F ^a   Mahfouz, Rami A ^a   Taher, Ali T ^b   Maarouf, Huda H ^c   Nassar, Anwar H ^c  

^a Laboratory Medicine

^b Internal Medicine

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Obstetric complication; Pregnancy outcome; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; FETUS DEATH; GENE MUTATION; HUMAN; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; LEBANON; MAJOR CLINICAL STUDY; MULTIPARA; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; REGISTER; SMOKING; STATISTICAL SIGNIFICANCE; THROMBOSIS; TRIAL OF LABOR;

ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; PROTHROMBIN;

EID: 33748780670     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.06.082     Document Type: Article

References (23)

1. Howley H.E., Walker M., and Rodger M.A. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 192 (2005) 694-708
2. Kujovich J.L. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 191 (2004) 412-424
3. Robertson L., Wu O., Langhorne P., Twaddle S., Clark P., Lowe G.D., et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132 (2006) 171-196
4. Dizon-Townson D., Miller C., Sibai B., Spong C.Y., Thom E., Wendel Jr. G., et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 106 (2005) 517-524
5. Alonso A., Soto I., Urgelles M.F., Corte J.R., Rodriguez M.J., and Pinto C.R. Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol 187 (2002) 1337-1342
6. Lin J., and August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105 (2005) 182-192
7. Kupferminc M.J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340 (1999) 9-13
8. Lockwood C.J. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 99 (2002) 333-341
9. Irani-Hakime N., Tamim H., Kreidy R., and Almawi W.Y. The prevalence factor V R506Q mutation-Leiden among apparently healthy Lebanese. Am J Hematol 65 (2000) 45-49
10. Taher A., Khalil I., Abou-Merhi R., Shamseddine A., and Bazarbachi A. High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon. Thromb Haemost 89 (2003) 945-946
11. Almawi W.Y., Finan R.R., Tamim H., Daccache J.L., and Irani-Hakime N. Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population. Am J Hematol 76 (2004) 85-87
12. Gerhardt A., Scharf R.E., Mikat-Drozdzynski B., Krussel J.S., Bender H.G., and Zotz R.B. The polymorphism of platelet membrane integrin alpha2beta1 (alpha2807TT) is associated with premature onset of fetal loss. Thromb Haemost 93 (2005) 124-129
13. Salomon O., Seligsohn U., Steinberg D.M., Zalel Y., Lerner A., Rosenberg N., et al. The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction. Am J Obstet Gynecol 191 (2004) 2002-2009
14. Kobashi G., Kato E.H., Morikawa M., Shimada S., Ohta K., Fujimoto S., et al. MTHFR C677T Polymorphism and factor V Leiden mutation are not associated with recurrent spontaneous abortion of unexplained etiology in Japanese women. Semin Thromb Hemost 31 (2005) 266-271
15. Stanley-Christian H., Ghidini A., Sacher R., and Shemirani M. Fetal genotype for specific inherited thrombophilias is not associated with severe preeclampsia. J Soc Gynecol Investig 12 (2005) 198-201
16. Gonen R., Lavi N., Attias D., Schliamser L., Borochowitz Z., Toubi E., et al. Absence of association of inherited thrombophilia with unexplained third-trimester intrauterine fetal death. Am J Obstet Gynecol 192 (2005) 742-746
17. American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia (2002), The College, Washington (DC) Practice bulletin no.: 33
18. Finan R.R., Tamim H., Ameen G., Sharida H.E., Rashid M., and Almawi W.Y. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol 71 (2002) 300-305
19. Rey E., Kahn S.R., David M., and Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361 (2003) 901-908
20. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215-1218
21. Grandone E., Margaglione M., Colaizzo D., d'Addedda M., Cappucci G., Vecchione G., et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost (1997) 77822-77824
22. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in the methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
23. Tranquilli A.L., Giannubilo S.R., Dell'Uomo B., and Grandone E. Adverse pregnancy outcomes are associated with multiple maternal thrombophilic factors. Eur J Obstet Gynecol Reprod Biol 117 (2004) 144-147